|
" Biochemistry and Molecular Genetics of Cancer Metastasis : "
edited by Karoly Lapis, Lance A. Liotta, Alan S. Rabson.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
713990
|
| Doc. No
|
:
|
b536139
|
| Main Entry
|
:
|
edited by Karoly Lapis, Lance A. Liotta, Alan S. Rabson.
|
| Title & Author
|
:
|
Biochemistry and Molecular Genetics of Cancer Metastasis : : Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis Bethesda, Maryland - March 18-20, 1985\ edited by Karoly Lapis, Lance A. Liotta, Alan S. Rabson.
|
| Publication Statement
|
:
|
Boston, MA: Springer US, 1986
|
| Series Statement
|
:
|
Developments in oncology, 41.
|
| Page. NO
|
:
|
(356 pages).
|
| ISBN
|
:
|
1461322995
|
|
|
:
|
: 9781461322993
|
| Contents
|
:
|
One --;Biochemistry and Molecular Biology Aspects --;1. Biochemical and molecular biology approaches to study cancer metastases --;2. Use of the chick embryo in studying the molecular genetics of metastasis --;3. Integral membrane adhesion glycoproteins: What is their fate during metastasis? --;4. Peptide fragments of fibronectin and laminin: Role in cell adhesion and inhibition of experimental tumor metastasis --;5. Role of ras oncogenes in experimental models of metastasis --;6. Expression of p21ras gene products in fresh primary and metastatic human tumor tissue --;7. A role for differentiation arrest in the development of neural crest tumors --;8. Genetic and epigenetic regulation of the metastatic phenotype: A basis for resolving the controversy regarding its selective or random nature and variable phenotypic stability --;9. Cytochemical cell typing of metastatic tumors according to their cytoskeletal proteins --;10. Biochemistry and molecular biology RAW117 large cell lymphoma --;11. Karyotypic progression and metastasis formation of human tumors --;12. Morphological and functional alterations of occludens, adherens, and gap junctions in cancer --;13. Pattern of basement membrane degradation by metastatic tumor cell enzymes --;Two --;Immunologic Mechanisms --;14. Gene products of the major histocompatibility complex control the metastatic phenotype of tumor cells --;15. Generation of metastatic cells via somatic cell fusion: A possible mechanism for tumor progression in-vivo --;16. The recognition and destruction of metastatic cells by tumoricidal macrophages --;17. Biological response modifiers for the therapy of metastases --;18. Differences in cell surface characteristics of poorly and highly metastatic Lewis lung tumor variants --;19. Characteristics of LL2 and its lectin-resistant not metastasizing variants --;20. A role for cell surface sialic acid in liberating metastatic tumor cells from host control --;Three --;Clinical Perspectives and Applications --;21. Tumor heterogeneity and empirical clinical cancer chemotherapy: Current status and future prospects --;22. Hormonal regulation of metastases: Prospects for pharmacological manipulation --;23. Use of anti-tumor MABs for diagnosis and immunotherapy of human tumors --;24. New approaches to the adoptive immunotherapy of established metastatic cancer using lymphokine-activated killer cells and recombinant interleukin-2 --;25. Preclinical screening of biological response modifiers: Application to the treatment of metastatic disease.
|
| Abstract
|
:
|
Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis, Bethesda, Maryland, March 18-20, 1985
|
| Subject
|
:
|
Biochemistry.
|
| Subject
|
:
|
Medicine.
|
| Subject
|
:
|
Oncology.
|
| Added Entry
|
:
|
Alan S Rabson
|
|
|
:
|
Karoly Lapis
|
|
|
:
|
L A Liotta
|
| Parallel Title
|
:
|
Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis, Bethesda, Maryland, March 18-20, 1985
|
| |